ARTICLE | Company News
J&J submits simeprevir application in Japan
February 23, 2013 1:22 AM UTC
Medivir AB (SSE:MVIR B) said partner Johnson & Johnson (NYSE:JNJ) submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for simeprevir ( TMC435) to treat HCV genot...